Nu Skin Enterprises (NYSE:NUS) Issues FY 2025 Earnings Guidance

Nu Skin Enterprises (NYSE:NUS) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 1.250-1.350 for the period, compared to the consensus estimate of 1.260. The company issued revenue guidance of $1.5 billion-$1.5 billion, compared to the consensus revenue estimate of $1.5 billion. Nu Skin Enterprises also updated its Q4 2025 guidance to 0.250-0.350 EPS.

Nu Skin Enterprises Stock Performance

NUS traded down $0.23 on Thursday, reaching $10.87. 523,959 shares of the stock were exchanged, compared to its average volume of 621,872. The firm has a market capitalization of $537.80 million, a PE ratio of 5.41 and a beta of 0.97. Nu Skin Enterprises has a fifty-two week low of $5.32 and a fifty-two week high of $14.62. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.01 and a quick ratio of 1.38. The company’s 50-day moving average price is $11.44 and its 200 day moving average price is $9.41.

Nu Skin Enterprises (NYSE:NUS) last posted its earnings results on Thursday, August 7th. The company reported $0.43 EPS for the quarter, beating the consensus estimate of $0.25 by $0.18. The firm had revenue of $386.14 million for the quarter, compared to analyst estimates of $376.68 million. Nu Skin Enterprises had a return on equity of 8.23% and a net margin of 6.20%. As a group, sell-side analysts forecast that Nu Skin Enterprises will post 1.05 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts have commented on NUS shares. Weiss Ratings reiterated a “hold (c)” rating on shares of Nu Skin Enterprises in a research note on Wednesday, October 8th. Zacks Research upgraded shares of Nu Skin Enterprises to a “hold” rating in a research report on Tuesday, August 12th. Finally, Wall Street Zen raised shares of Nu Skin Enterprises from a “buy” rating to a “strong-buy” rating in a report on Sunday, October 12th. Three equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $7.00.

Insider Transactions at Nu Skin Enterprises

In related news, Director Daniel W. Campbell sold 23,391 shares of the stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $12.10, for a total transaction of $283,031.10. Following the transaction, the director owned 53,375 shares of the company’s stock, valued at approximately $645,837.50. This represents a 30.47% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Chayce David Clark sold 20,000 shares of the stock in a transaction that occurred on Wednesday, September 3rd. The stock was sold at an average price of $11.97, for a total value of $239,400.00. Following the sale, the executive vice president directly owned 233,140 shares of the company’s stock, valued at $2,790,685.80. The trade was a 7.90% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 58,926 shares of company stock worth $711,364 over the last three months. 2.00% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Tower Research Capital LLC TRC boosted its position in Nu Skin Enterprises by 107.4% in the second quarter. Tower Research Capital LLC TRC now owns 5,048 shares of the company’s stock valued at $40,000 after buying an additional 2,614 shares during the last quarter. Man Group plc grew its holdings in Nu Skin Enterprises by 209.6% during the second quarter. Man Group plc now owns 247,992 shares of the company’s stock worth $1,981,000 after acquiring an additional 167,902 shares during the period. BNP Paribas Financial Markets lifted its position in shares of Nu Skin Enterprises by 2.7% in the second quarter. BNP Paribas Financial Markets now owns 348,646 shares of the company’s stock valued at $2,786,000 after acquiring an additional 9,052 shares in the last quarter. Bridgeway Capital Management LLC lifted its position in Nu Skin Enterprises by 330.2% during the second quarter. Bridgeway Capital Management LLC now owns 215,124 shares of the company’s stock worth $1,719,000 after buying an additional 165,124 shares during the period. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main purchased a new position in shares of Nu Skin Enterprises in the 2nd quarter worth about $174,000. Institutional investors and hedge funds own 82.84% of the company’s stock.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.